Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Digestive System”

17,939 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 17,939 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05621707
What this trial is testing

Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)

Who this might be right for
Esophageal Squamous Cell CarcinomasConcurrent ChemoradiotherapyImmunotherapy+1 more
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)UnknownNCT03803436
What this trial is testing

Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation

Who this might be right for
Liver MetastasesColorectal Cancer MetastaticLiver Neoplasm+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 22
Not applicableStudy completedNCT02192333
What this trial is testing

Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors

Who this might be right for
Breast CarcinomaCancer SurvivorDepression+10 more
Fred Hutchinson Cancer Center 390
Testing effectiveness (Phase 2)WithdrawnNCT06557278
What this trial is testing

Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Mirror Biologics, Inc.
Not applicableEnrolling By InvitationNCT07050485
What this trial is testing

Postbiotics for Mitigation of Postoperative Dysbiosis in Gastrointestinal Cancer Surgery

Who this might be right for
Colon CancerGastrointestinal Cancer
University of South Florida 30
Not applicableStudy completedNCT04846985
What this trial is testing

Nutritional Problems in Pallative Cancer

Who this might be right for
Lung CancerPancreatic Cancer
Jens Rikardt Andersen 44
Not applicableLooking for participantsNCT02864485
What this trial is testing

Living Donor Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT02923934
What this trial is testing

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Who this might be right for
Gastrointestinal CancerNeuroendocrine TumoursMalignant Female Reproductive System Neoplasm
Olivia Newton-John Cancer Research Institute 120
Not applicableStudy completedNCT03758209
What this trial is testing

Prehabilitation Versus Enhanced Recovery Program for Elective Colorectal Cancer Surgery.

Who this might be right for
Colorectal CancerInsulin Resistance
St. Borbala Hospital 184
Testing effectiveness (Phase 2)Study completedNCT00828984
What this trial is testing

Macrogol 3350-based Oral Osmotic Laxative in Preventing Cancer in Patients at Risk of Colorectal Cancer

Who this might be right for
Adenomatous PolypColorectal Carcinoma
National Cancer Institute (NCI) 87
Not applicableStudy completedNCT02454647
What this trial is testing

Induction Chemotherapy, Chemoradiotherapy and Surgery in Locally Advanced Gastric Cancer Patients

Who this might be right for
Gastric CancerAdenocarcinomaEffects of Chemotherapy+2 more
Clinica Universidad de Navarra, Universidad de Navarra 46
Large-scale testing (Phase 3)Ended earlyNCT05328908
What this trial is testing

Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Bristol-Myers Squibb 770
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Post-approval studies (Phase 4)Not Yet RecruitingNCT06665334
What this trial is testing

To Explore the Effect of Huaier Granule on the Negative Conversion Rate After the CEA Level Increases Again After Colorectal Cancer Surgery

Who this might be right for
Colorectal Cancer
Fudan University 134
Not applicableUnknownNCT00689364
What this trial is testing

Comprehensive Therapy to Relieving the Risk of Recurrence and Metastasis for Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ministry of Science and Technology of the People´s Republic of China 480
Not applicableLooking for participantsNCT06043999
What this trial is testing

Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients

Who this might be right for
Chemotherapy EffectRectal Cancer
Sun Yat-sen University 392
Large-scale testing (Phase 3)Study completedNCT03511963
What this trial is testing

A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai Henlius Biotech 677
Not applicableStudy completedNCT04566614
What this trial is testing

Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

Who this might be right for
Neoplasm, ColorectalNeoplasm of LungNeoplasm, Bladder+3 more
Royal Marsden NHS Foundation Trust 128
Not applicableWithdrawnNCT05356585
What this trial is testing

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Colorectal CancerRectal Cancer
Case Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT04330664
What this trial is testing

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86
Load More Results